ea0041gp14 | Adrenal (1) | ECE2016
Nilsson Anna
, Bergthorsdottir Ragnhildur
, Burman Pia
, Dahlqvist Per
, Ekman Bertil
, Eden Engstrom Britt
, Ragnarsson Oskar
, Skrtic Stanko
, Wahlberg Jeanette
, Achenbach Heinrich
, Uddin Sharif
, Marelli Claudio
, Johannsson Gudmundur
Introduction: Glucocorticoid replacement for adrenal insufficiency (AI) remains inadequate, resulting in high morbidity, premature mortality and quality-of-life (QoL) impairment. This study investigated the long-term safety of dual-release hydrocortisone (DR-HC) in patients with primary AI.Methods: AI patients who completed a randomized, 3-month crossover study of once-daily DR-HC versus thrice-daily conventional immediate-release hydrocortisone plus a 6...